Publication | Closed Access

In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates

Antimicrobial SusceptibilityHealth SciencesAntibioticsSiderophore Monosulfactam Bal30072New York CityAntimicrobial ChemotherapyMicrobiologyInfection ControlAntimicrobial CompoundContemporary Gram-negative PathogensMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance